vs

Side-by-side financial comparison of American Well Corp (AMWL) and BICYCLE THERAPEUTICS PLC (BCYC). Click either name above to swap in a different company.

American Well Corp is the larger business by last-quarter revenue ($55.3M vs $48.0M, roughly 1.2× BICYCLE THERAPEUTICS PLC). BICYCLE THERAPEUTICS PLC runs the higher net margin — -42.0% vs -45.1%, a 3.0% gap on every dollar of revenue. On growth, BICYCLE THERAPEUTICS PLC posted the faster year-over-year revenue change (1193.3% vs -22.1%). American Well Corp produced more free cash flow last quarter ($-17.4M vs $-19.9M). Over the past eight quarters, BICYCLE THERAPEUTICS PLC's revenue compounded faster (56.7% CAGR vs -3.6%).

The American Tobacco Company was a tobacco company founded in 1890 by J. B. Duke through a merger between a number of U.S. tobacco manufacturers including Allen and Ginter, Goodwin & Company, and Kinney Brothers. The company was one of the original 12 members of the Dow Jones Industrial Average in 1896. The American Tobacco Company dominated the industry by acquiring the Lucky Strike Company and over 200 other rival firms. Federal Antitrust action begun in 1907 broke the company into several ...

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical firm developing innovative bicyclic peptide therapies for unmet medical needs. Its core pipeline covers oncology, rare diseases, and immunological disorders, with operations in Europe and North America, and partnerships with global pharma leaders to advance drug candidates to market.

AMWL vs BCYC — Head-to-Head

Bigger by revenue
AMWL
AMWL
1.2× larger
AMWL
$55.3M
$48.0M
BCYC
Growing faster (revenue YoY)
BCYC
BCYC
+1215.4% gap
BCYC
1193.3%
-22.1%
AMWL
Higher net margin
BCYC
BCYC
3.0% more per $
BCYC
-42.0%
-45.1%
AMWL
More free cash flow
AMWL
AMWL
$2.6M more FCF
AMWL
$-17.4M
$-19.9M
BCYC
Faster 2-yr revenue CAGR
BCYC
BCYC
Annualised
BCYC
56.7%
-3.6%
AMWL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AMWL
AMWL
BCYC
BCYC
Revenue
$55.3M
$48.0M
Net Profit
$-24.9M
$-20.2M
Gross Margin
Operating Margin
-45.5%
-51.5%
Net Margin
-45.1%
-42.0%
Revenue YoY
-22.1%
1193.3%
Net Profit YoY
41.6%
61.1%
EPS (diluted)
$-1.53
$-0.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMWL
AMWL
BCYC
BCYC
Q4 25
$55.3M
$48.0M
Q3 25
$56.3M
$11.7M
Q2 25
$70.9M
$2.9M
Q1 25
$66.8M
$10.0M
Q4 24
$71.0M
$3.7M
Q3 24
$61.0M
$2.7M
Q2 24
$62.8M
$9.4M
Q1 24
$59.5M
$19.5M
Net Profit
AMWL
AMWL
BCYC
BCYC
Q4 25
$-24.9M
$-20.2M
Q3 25
$-32.4M
$-59.1M
Q2 25
$-19.7M
$-79.0M
Q1 25
$-18.7M
$-60.8M
Q4 24
$-42.7M
Q3 24
$-43.5M
$-50.8M
Q2 24
$-49.9M
$-39.8M
Q1 24
$-72.1M
$-26.6M
Operating Margin
AMWL
AMWL
BCYC
BCYC
Q4 25
-45.5%
-51.5%
Q3 25
-52.1%
-558.6%
Q2 25
-28.7%
-2965.8%
Q1 25
-45.5%
-703.7%
Q4 24
-60.2%
Q3 24
-77.6%
-2385.9%
Q2 24
-83.4%
-498.3%
Q1 24
-126.1%
-162.4%
Net Margin
AMWL
AMWL
BCYC
BCYC
Q4 25
-45.1%
-42.0%
Q3 25
-57.5%
-503.7%
Q2 25
-27.8%
-2703.8%
Q1 25
-28.0%
-608.9%
Q4 24
-60.1%
Q3 24
-71.2%
-1898.4%
Q2 24
-79.5%
-425.3%
Q1 24
-121.1%
-136.0%
EPS (diluted)
AMWL
AMWL
BCYC
BCYC
Q4 25
$-1.53
$-0.29
Q3 25
$-2.00
$-0.85
Q2 25
$-1.24
$-1.14
Q1 25
$-1.19
$-0.88
Q4 24
$-2.71
Q3 24
$-2.87
$-0.74
Q2 24
$-3.36
$-0.77
Q1 24
$-4.94
$-0.62

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMWL
AMWL
BCYC
BCYC
Cash + ST InvestmentsLiquidity on hand
$182.3M
$628.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$235.6M
$610.0M
Total Assets
$323.8M
$717.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMWL
AMWL
BCYC
BCYC
Q4 25
$182.3M
$628.1M
Q3 25
$200.9M
$648.3M
Q2 25
$219.1M
$721.5M
Q1 25
$222.4M
$793.0M
Q4 24
$228.3M
$879.5M
Q3 24
$244.6M
$890.9M
Q2 24
$276.9M
$961.4M
Q1 24
$308.6M
$457.0M
Total Debt
AMWL
AMWL
BCYC
BCYC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$30.9M
Q1 24
$30.8M
Stockholders' Equity
AMWL
AMWL
BCYC
BCYC
Q4 25
$235.6M
$610.0M
Q3 25
$254.9M
$618.5M
Q2 25
$282.6M
$668.9M
Q1 25
$294.0M
$740.3M
Q4 24
$304.8M
$793.1M
Q3 24
$336.7M
$831.0M
Q2 24
$363.9M
$873.8M
Q1 24
$408.7M
$356.0M
Total Assets
AMWL
AMWL
BCYC
BCYC
Q4 25
$323.8M
$717.6M
Q3 25
$359.4M
$764.0M
Q2 25
$388.7M
$832.2M
Q1 25
$419.5M
$883.9M
Q4 24
$436.0M
$956.9M
Q3 24
$483.0M
$996.7M
Q2 24
$507.8M
$1.1B
Q1 24
$548.4M
$547.1M
Debt / Equity
AMWL
AMWL
BCYC
BCYC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.04×
Q1 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMWL
AMWL
BCYC
BCYC
Operating Cash FlowLast quarter
$-17.4M
$-19.3M
Free Cash FlowOCF − Capex
$-17.4M
$-19.9M
FCF MarginFCF / Revenue
-31.4%
-41.5%
Capex IntensityCapex / Revenue
0.0%
1.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-252.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMWL
AMWL
BCYC
BCYC
Q4 25
$-17.4M
$-19.3M
Q3 25
$-18.8M
$-71.2M
Q2 25
$-4.7M
$-72.8M
Q1 25
$-25.1M
$-86.4M
Q4 24
$-13.4M
$-164.7M
Q3 24
$-32.4M
$-39.8M
Q2 24
$-21.8M
$-44.6M
Q1 24
$-59.8M
$-70.9M
Free Cash Flow
AMWL
AMWL
BCYC
BCYC
Q4 25
$-17.4M
$-19.9M
Q3 25
$-71.8M
Q2 25
$-73.3M
Q1 25
$-25.1M
$-87.0M
Q4 24
$-13.4M
$-166.0M
Q3 24
$-32.4M
$-40.3M
Q2 24
$-21.8M
$-45.0M
Q1 24
$-59.8M
$-70.9M
FCF Margin
AMWL
AMWL
BCYC
BCYC
Q4 25
-31.4%
-41.5%
Q3 25
-612.3%
Q2 25
-2509.7%
Q1 25
-37.6%
-871.7%
Q4 24
-18.9%
-4475.7%
Q3 24
-53.0%
-1504.7%
Q2 24
-34.7%
-481.2%
Q1 24
-100.5%
-362.9%
Capex Intensity
AMWL
AMWL
BCYC
BCYC
Q4 25
0.0%
1.2%
Q3 25
0.0%
5.7%
Q2 25
0.0%
17.1%
Q1 25
0.0%
6.1%
Q4 24
0.0%
33.3%
Q3 24
0.0%
16.3%
Q2 24
0.0%
4.5%
Q1 24
0.1%
0.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMWL
AMWL

Platform Subscription$28.8M52%
Visits$23.7M43%
Others$2.8M5%

BCYC
BCYC

Segment breakdown not available.

Related Comparisons